TOP message

The COVID-19 pandemic has generally subsided, marking a major social and economic turning point on a global scale. The major changes brought about by the pandemic have had a profound impact on people’s lives.

In this environment, the Group has formulated the “NOF Vision 2030” as a strategic policy for the future, based on the establishment of new values and technological advances. The 2025 Mid-Term Management Plan, a stage positioned for expanding profit within the policy, has commenced this fiscal year. In the first half of the current fiscal year, the first year of our new Mid-Term Management Plan, although the Functional Chemicals Segment faced a challenging business environment, the Pharmaceuticals, Medicals and Health Segment performed well, making steady progress against the annual plan. The interim dividend has been set at ¥56 per share (an increase of ¥6 from the previous year’s interim dividend), and the amount allocated for the purchase of treasury stock has been set at ¥3,000 million.

In addition, concerning the forecast of our consolidated financial results for the current fiscal year, we have revised upward the figures announced in May 2023 for operating income, ordinary income, and profit attributable to owners of parent, based on the current business environment and demand forecast.

The Group aims to make a leap forward as a global company through innovative approaches and proactive reforms. We will provide products and services that meet new needs while fully leveraging the possibilities offered by technological advances and responding swiftly to market changes. We will promote business activities that emphasize sustainability and social responsibility in order to meet the demands of society while keeping up with changing values.

Today, there is rapidly increasing interest in various social issues, including global environmental issues such as climate change as well as human rights issues. The Group will face social changes with sincerity, endeavor to create new value with the power of chemistry, and continue to meet the expectations of all of our stakeholders, with the aim of achieving a secure and affluent society.

We kindly ask all shareholders for your continuing support.

November 2023

Kojj Sawamura
President & Chief Executive Officer